Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69f43505d1b3ec31c224b32b5d1ec4e2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2005-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78b343112d373b9d279b6be3cfff1ba5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76f6e4d59f104446e28829ac81199a31 |
publicationDate |
2006-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20060121602-A |
titleOfInvention |
Pharmaceutical composition for the treatment of cancer diseases comprising H4 antibody and immunotherapy method of cancer using the same |
abstract |
The present invention relates to HBBK4, a humanized antibody effective for the treatment of cancer diseases. More specifically, the present invention provides a pharmaceutical composition for the treatment of cancer diseases, including HBBK4, a humanized anti-4-1BB antibody, via a CD11c + CD8 + T cell population whose cancer cell removal ability has been confirmed in animal experiments, and a method for immunotherapy of cancer. to provide. |
priorityDate |
2005-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |